细胞周期蛋白依赖性激酶抑制剂：细胞周期调控中的有用靶点。 - Suppr

Suppr

超能文献

Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation.

作者信息

Sielecki T M, Boylan J F, Benfield P A, Trainor G L

机构信息

The DuPont Pharmaceuticals Company, P.O. Box 80500, Wilmington, Delaware 19880-0500, USA.

出版信息

J Med Chem. 2000 Jan 13;43(1):1-18.

PMID:10633033

Abstract

摘要

相似文献

Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation.

J Med Chem. 2000 Jan 13;43(1):1-18.

Discovery of the antiviral activities of pharmacologic cyclin-dependent kinase inhibitors: from basic to applied science.

Expert Rev Anti Infect Ther. 2005 Apr;3(2):145-9. doi: 10.1586/14787210.3.2.145.

Cyclin-dependent kinase inhibitors.

Prog Cell Cycle Res. 2003;5:235-48.

Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.

Oncogene. 2003 Nov 13;22(51):8271-82. doi: 10.1038/sj.onc.1207158.

Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development.

Cancer J. 2000 Jul-Aug;6(4):192-212.

Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.

J Cell Physiol. 2003 Dec;197(3):326-35. doi: 10.1002/jcp.10393.

CDK inhibitors in cancer therapy: what is next?

Trends Pharmacol Sci. 2008 Jan;29(1):16-21. doi: 10.1016/j.tips.2007.10.012. Epub 2007 Dec 4.

Cyclin-dependent kinase modulators: a novel class of cell cycle regulators for cancer therapy.

Cancer Chemother Biol Response Modif. 2001;19:165-88.

p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.

Oncogene. 2002 Sep 19;21(42):6413-24. doi: 10.1038/sj.onc.1205908.

[G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].

Tsitologiia. 2002;44(7):649-55.

引用本文的文献

A Pharmacological Overview and Recent Patent of Triazine Scaffold in Drug Development: A Review.

Curr Org Synth. 2025;22(3):310-327. doi: 10.2174/0115701794272212240307092318.

Evaluation of Triazine Scaffold for Anticancer Drug Development: A Review.

Curr Drug Discov Technol. 2024;21(2):e170723218813. doi: 10.2174/1570163820666230717161610.

An Effective Synthesis of Previously Unknown 7-Aryl Substituted Paullones.

Molecules. 2023 Mar 2;28(5):2324. doi: 10.3390/molecules28052324.

Contribution of Cyclin-dependent Kinase Inhibitor 1B Genotypes to Childhood Leukemia Risk.

In Vivo. 2022 Jul-Aug;36(4):1637-1642. doi: 10.21873/invivo.12874.

1,3-diarylpyrazolones as potential anticancer agents for non-small cell lung cancer: Synthesis and antiproliferative activity evaluation.

Chem Biol Drug Des. 2022 Apr;99(4):620-633. doi: 10.1111/cbdd.14030. Epub 2022 Mar 1.

Nuclear dihydroxyacetone phosphate signals nutrient sufficiency and cell cycle phase to global histone acetylation.

Nat Metab. 2021 Jun;3(6):859-875. doi: 10.1038/s42255-021-00405-8. Epub 2021 Jun 17.

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives.

Signal Transduct Target Ther. 2021 May 31;6(1):201. doi: 10.1038/s41392-021-00572-w.

Role of the base CsCO on the palladium-catalyzed intramolecular cyclization of two bromoindole derivatives to yield paullone-type products.

J Mol Model. 2021 Jan 3;27(1):9. doi: 10.1007/s00894-020-04638-4.

-Vanillin Derived Schiff Bases and Their Organotin(IV) Compounds: Synthesis, Structural Characterisation, In-Silico Studies and Cytotoxicity.

Int J Mol Sci. 2019 Feb 15;20(4):854. doi: 10.3390/ijms20040854.

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors.

J Vis Exp. 2015 Oct 26(105):e52441. doi: 10.3791/52441.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验